What is Histogen?
Histogen Inc. is dedicated to pioneering first-in-class restorative therapeutics designed to ignite the body's inherent capacity for biological repair and maintenance. The company's innovative technology platform is centered on cell conditioned media and extracellular matrix materials derived from hypoxia-induced multipotent cells. Histogen's proprietary and reproducible manufacturing process enables the delivery of targeted solutions across a diverse spectrum of therapeutic indications, including joint cartilage regeneration, spinal disk repair, and various soft tissue repair applications such as tendons and ligaments.
How much funding has Histogen raised?
Histogen has raised a total of $37.3M across 6 funding rounds:
Private Equity
$9.5M
Private Equity
$6M
Debt
$350K
Share Placement
$10M
Stock Offering
$6.5M
Share Placement
$5M
Private Equity (2007): $9.5M, investors not publicly disclosed
Private Equity (2016): $6M led by Huapont Life Sciences Co.
Debt (2020): $350K supported by PPP
Share Placement (2020): $10M, investors not publicly disclosed
Stock Issuance/Offering (2021): $6.5M, investors not publicly disclosed
Share Placement (2022): $5M, investors not publicly disclosed
Key Investors in Histogen
Huapont Life Sciences Co.
Huapont Life Sciences Co. is a prominent pharmaceutical manufacturer with a broad portfolio, including dermatological, respiratory, and anti-tumor treatments. Their involvement suggests a strategic interest in Histogen's therapeutic applications and potential for market synergy.
What's next for Histogen?
With the recent influx of major strategic investment, Histogen is poised for a significant scaling phase. This capital infusion is anticipated to fuel further clinical development, enhance manufacturing capabilities, and potentially expand its therapeutic pipeline. The company's focus on restorative medicine positions it to address unmet needs in regenerative therapies, suggesting a strategic push towards market penetration and broader clinical application of its unique technology platform.
See full Histogen company page
